When comparing both pandemic periods with the pre-pandemic one, a statistical reduction was observed in Phe levels in pediatric and adult PKU patients (in adults in both pandemic periods in contrast to the pre-pandemic one and in children in pandemic period 2), in Gal 1-P levels in galactosemia patients and in glutamine levels in pandemic period 2. The gene discussed is LGALS1; the disease is phenylketonuria.